Crinetics Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 6.06, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Crinetics Pharmaceuticals Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 60 days, from 32 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 523 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 975 to 3808.

What is Receivable Turnover Ratio?
What is Crinetics Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CRNX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	2336.28 %	2873.41 %	-	-	158.4 %
Receivable Turnover Ratio (TTM)	6.06	11.52	52	-	-
CRNX's Total Ranking	# 3808	# 975	# 3403	# 0	# 0
Accounts Receivable average collection period days	60	32	7	-	-
Seq. Receivable Change	279.32 %	859.97 %	-	-	-
Seq. Revenue Change	134 %	74.22 %	4208.39 %	-86.13 %	185.6 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 178
Healthcare Sector	# 524
Overall Market	# 3808

Receivable Turnover Ratio Statistics
High	Average	Low
0.03	0.01	0
(Jun 30 2026)		(Jun 30 2018)

CRNX Company Profile • Back to CRNX Efficiency Comparisons • Compare CRNX Receivables Turnover Ratio to its Competitors

Financial Statements
Crinetics Pharmaceuticals Inc 's Accounts Receivable	$ 22 Millions	Visit CRNX's Balance sheet
Crinetics Pharmaceuticals Inc 's Sales TTM	$ 42 Millions	Visit CRNX's Income Statement
Sources of CRNX's Revenues		Visit CRNX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CRNX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CRNX's Growth Rates	CRNX's Roa	CRNX's Inventory Turnover Ratio	CRNX's Dividend Comparisons
CRNX's Profitability Ratios	CRNX's Roi	CRNX's Asset Turnover Ratio	CRNX's Dividend Growth
CRNX's Valuation Ratios	CRNX's Roe	CRNX's Financial Strength Ratios	CRNX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Sintx Technologies Inc	5.37	$ 1.330 Millions	$ 0.248 Millions
Igc Pharma Inc	5.36	$ 1.101 Millions	$ 0.206 Millions
Cytokinetics Incorporated	5.33	$ 67.670 Millions	$ 12.708 Millions
Strata Critical Medical Inc	5.27	$ 211.642 Millions	$ 40.126 Millions
Karyopharm Therapeutics Inc	5.27	$ 146.621 Millions	$ 27.821 Millions
Enovis Corp	5.21	$ 2,294.938 Millions	$ 440.151 Millions
The Cooper Companies Inc	5.20	$ 4,236.600 Millions	$ 814.025 Millions
Cryoport inc	5.19	$ 186.452 Millions	$ 35.933 Millions
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
Pluri Inc	5.15	$ 1.016 Millions	$ 0.197 Millions
Opus Genetics Inc	5.13	$ 9.856 Millions	$ 1.921 Millions
Carlsmed Inc	5.13	$ 62.457 Millions	$ 12.175 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Progyny Inc	5.09	$ 1,311.298 Millions	$ 257.570 Millions
Pacific Biosciences Of California Inc	5.04	$ 159.315 Millions	$ 31.630 Millions
Sarepta Therapeutics Inc	5.03	$ 1,974.344 Millions	$ 392.275 Millions
Amphastar Pharmaceuticals Inc	5.01	$ 730.019 Millions	$ 145.768 Millions
Zimmer Biomet Holdings Inc	5.00	$ 8,508.800 Millions	$ 1,700.200 Millions
Abbvie Inc	4.99	$ 64,386.000 Millions	$ 12,915.250 Millions
Pfizer Inc	4.98	$ 63,696.000 Millions	$ 12,802.250 Millions
Stereotaxis Inc	4.98	$ 29.892 Millions	$ 6.008 Millions
Invivyd Inc	4.96	$ 58.365 Millions	$ 11.776 Millions
Agilent Technologies inc	4.96	$ 7,372.000 Millions	$ 1,487.500 Millions
Cytosorbents Corporation	4.93	$ 35.663 Millions	$ 7.229 Millions
Champions Oncology Inc	4.90	$ 60.662 Millions	$ 12.388 Millions
Mirum Pharmaceuticals Inc	4.86	$ 618.067 Millions	$ 127.234 Millions
Indivior Pharmaceuticals Inc	4.85	$ 1,333.000 Millions	$ 274.750 Millions
Ultragenyx Pharmaceutical Inc	4.85	$ 717.212 Millions	$ 147.886 Millions
Abeona Therapeutics Inc	4.83	$ 30.093 Millions	$ 6.232 Millions

Date modified: 2026-09-13T23:45:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.